These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 3126240)

  • 1. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
    Gorelik E; Jay G; Kwiatkowski B; Herberman RB
    J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine.
    Gorelik E; Peppoloni S; Overton R; Herberman RB
    Cancer Res; 1985 Nov; 45(11 Pt 1):5341-7. PubMed ID: 2413992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for indirect involvement of the H-2Kb gene in the regulation of natural killer sensitivity of BL6 melanoma cells.
    Kim M; Herberman R; Gorelik E
    Nat Immun; 1994; 13(1):1-14. PubMed ID: 8111189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.
    Kim M; Duty L; Herberman R; Gorelik E
    Cell Immunol; 1994 May; 155(2):358-71. PubMed ID: 8181071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
    Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
    J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of H-2Kb gene on expression of melanoma-associated antigen and lectin-binding sites on BL6 melanoma cells.
    Gorelik E; Jay G; Kim M; Hearing VJ; DeLeo A; McCoy JP
    Cancer Res; 1991 Oct; 51(19):5212-8. PubMed ID: 1913644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
    Piontek GE; Taniguchi K; Ljunggren HG; Grönberg A; Kiessling R; Klein G; Kärre K
    J Immunol; 1985 Dec; 135(6):4281-8. PubMed ID: 3905967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
    J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
    Begovic M; Herberman R; Gorelik E
    Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.
    Ljunggren HG; Sturmhöfel K; Wolpert E; Hämmerling GJ; Kärre K
    J Immunol; 1990 Jul; 145(1):380-6. PubMed ID: 2113557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules.
    Kubota A; Lian RH; Lohwasser S; Salcedo M; Takei F
    J Immunol; 1999 Dec; 163(12):6488-93. PubMed ID: 10586040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Karlhofer FM; Ribaudo RK; Yokoyama WM
    Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
    Brooks CG; Holscher M; Urdal D
    J Immunol; 1985 Aug; 135(2):1145-52. PubMed ID: 2409140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells.
    de Fries RU; Golub SH
    J Immunol; 1988 May; 140(10):3686-93. PubMed ID: 3129500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression.
    Salazar-Onfray F; Petersson M; Franksson L; Matsuda M; Blankenstein T; Kärre K; Kiessling R
    J Immunol; 1995 Jun; 154(12):6291-8. PubMed ID: 7759867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.